Gastrointestinal Bleeding From Duodenal Aberrant Pancreas After Antiangiogenic Therapy.
Departments of *Internal Medicine Second Division †Clinical Oncology ‡Clinical Pharmacology and Therapeutics Hamamatsu University School of Medicine Hamamatsu, Japan.
Koji
K
Nishimoto
Masato
M
Karayama
Norimichi
N
Akiyama
Seiichiro
S
Suzuki
Yusuke
Y
Inoue
Masato
M
Kono
Hironao
H
Hozumi
Yuzo
Y
Suzuki
Kazuki
K
Furuhashi
Noriyuki
N
Enomoto
Tomoyuki
T
Fujisawa
Yutaro
Y
Nakamura
Naoki
N
Inui
Takafumi
T
Suda
D000230:Adenocarcinoma / Q000188:drug therapy; D020533:Angiogenesis Inhibitors / Q000009:adverse effects*; D000068258:Bevacizumab / Q000009:adverse effects*; D002828:Choristoma / Q000150:complications*; D004378:Duodenal Diseases / Q000150:complications*; D006471:Gastrointestinal Hemorrhage / Q000209:etiology*; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D010179:Pancreas
D020533:Angiogenesis Inhibitors; D000068258:Bevacizumab